$0.00424
-0.00045-9.50%
At close: -
Comments
Loading...
Mydecine Innovations Gr Analyst Ratings and Price Targets | OTC:MYCOF | Benzinga
Mydecine Innovations Gr Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Mydecine Innovations Gr Corp from these most-recent analyst ratings.
Analyst Ratings for Mydecine Innovations Gr
Data brought to you by Benzinga APIs
FAQ
What is the target price for Mydecine Innovations Gr (MYCOF) stock?
There is no price target for Mydecine Innovations Gr
What is the most recent analyst rating for Mydecine Innovations Gr (MYCOF)?
There is no analyst for Mydecine Innovations Gr
When was the last upgrade for Mydecine Innovations Gr (MYCOF)?
There is no last upgrade for Mydecine Innovations Gr
When was the last downgrade for Mydecine Innovations Gr (MYCOF)?
There is no last downgrade for Mydecine Innovations Gr.
When is the next analyst rating going to be posted or updated for Mydecine Innovations Gr (MYCOF)?
There is no next analyst rating for Mydecine Innovations Gr.
Is the Analyst Rating Mydecine Innovations Gr (MYCOF) correct?
There is no next analyst rating for Mydecine Innovations Gr.
Browse analyst ratings and price targets on all stocks.